Improve Medical Instruments Co., Ltd. (SHE:300030)
China
· Delayed Price · Currency is CNY 8.17
+0.17 (2.13%)
Apr 29, 2026, 3:04 PM CST
SHE:300030 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Operating Revenue | 462.06 | 482.29 | 575.33 | 635.17 | 705.16 | 793.98 | Upgrade
|
| Other Revenue | 3.97 | 3.97 | 5.99 | 9.45 | 5.61 | 5.86 | Upgrade
|
| Revenue | 466.04 | 486.26 | 581.33 | 644.62 | 710.77 | 799.83 | Upgrade
|
| Revenue Growth (YoY) | -16.14% | -16.35% | -9.82% | -9.31% | -11.14% | -12.99% | Upgrade
|
| Cost of Revenue | 267.09 | 289.12 | 368.51 | 414.5 | 474.56 | 490.54 | Upgrade
|
| Gross Profit | 198.95 | 197.14 | 212.81 | 230.12 | 236.21 | 309.29 | Upgrade
|
| Selling, General & Admin | 134.18 | 140.33 | 180.76 | 225.16 | 239.4 | 219.24 | Upgrade
|
| Research & Development | 21.98 | 23.65 | 31.9 | 37.52 | 43.67 | 42.33 | Upgrade
|
| Other Operating Expenses | 2.36 | 1.77 | 6.11 | 4.03 | 4.96 | 7.08 | Upgrade
|
| Operating Expenses | 153.24 | 160.47 | 242.72 | 263.62 | 297.12 | 276.4 | Upgrade
|
| Operating Income | 45.71 | 36.67 | -29.91 | -33.5 | -60.91 | 32.89 | Upgrade
|
| Interest Expense | -5.14 | -5.14 | -11.09 | -16.56 | -19.7 | -25.44 | Upgrade
|
| Interest & Investment Income | 18.26 | 21.57 | 1.82 | 8.55 | 2.45 | 20.76 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.09 | 0.09 | 1.2 | -0.84 | 2.38 | -1.56 | Upgrade
|
| Other Non Operating Income (Expenses) | 13.03 | 0.52 | 0.67 | -3.51 | -2.11 | -6.53 | Upgrade
|
| EBT Excluding Unusual Items | 71.95 | 53.72 | -37.31 | -45.87 | -77.89 | 20.11 | Upgrade
|
| Impairment of Goodwill | -7.8 | -7.8 | -11.87 | -2.93 | -53.62 | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -10.17 | -10.17 | -63.56 | 1.21 | -53.1 | 6.41 | Upgrade
|
| Gain (Loss) on Sale of Assets | 1.89 | 2.09 | 0.9 | 6.45 | 0.44 | 0.02 | Upgrade
|
| Asset Writedown | -14.79 | -14.79 | -11.47 | -6.05 | -36.45 | -1.39 | Upgrade
|
| Legal Settlements | - | - | - | -2.44 | -0.56 | - | Upgrade
|
| Other Unusual Items | -0.32 | -0.32 | 2.96 | 6.57 | 6.88 | -1.3 | Upgrade
|
| Pretax Income | 40.75 | 22.72 | -120.35 | -43.06 | -214.3 | 23.84 | Upgrade
|
| Income Tax Expense | 11.42 | 7.5 | -0.45 | 17.16 | -21.01 | 4.07 | Upgrade
|
| Earnings From Continuing Operations | 29.33 | 15.21 | -119.9 | -60.22 | -193.29 | 19.77 | Upgrade
|
| Minority Interest in Earnings | -0.92 | -0.68 | 2 | -2.98 | -5.01 | -1.2 | Upgrade
|
| Net Income | 28.4 | 14.53 | -117.9 | -63.2 | -198.3 | 18.57 | Upgrade
|
| Net Income to Common | 28.4 | 14.53 | -117.9 | -63.2 | -198.3 | 18.57 | Upgrade
|
| Net Income Growth | - | - | - | - | - | -88.57% | Upgrade
|
| Shares Outstanding (Basic) | 303 | 291 | 310 | 316 | 310 | 309 | Upgrade
|
| Shares Outstanding (Diluted) | 303 | 291 | 310 | 316 | 310 | 309 | Upgrade
|
| Shares Change (YoY) | 2.50% | -6.34% | -1.82% | 1.99% | 0.12% | 0.93% | Upgrade
|
| EPS (Basic) | 0.09 | 0.05 | -0.38 | -0.20 | -0.64 | 0.06 | Upgrade
|
| EPS (Diluted) | 0.09 | 0.05 | -0.38 | -0.20 | -0.64 | 0.06 | Upgrade
|
| EPS Growth | - | - | - | - | - | -88.68% | Upgrade
|
| Free Cash Flow | 99.76 | 85.77 | 30.55 | 36.2 | -15.56 | 100.69 | Upgrade
|
| Free Cash Flow Per Share | 0.33 | 0.29 | 0.10 | 0.12 | -0.05 | 0.33 | Upgrade
|
| Dividend Per Share | - | - | - | - | - | 0.040 | Upgrade
|
| Dividend Growth | - | - | - | - | - | 25.00% | Upgrade
|
| Gross Margin | 42.69% | 40.54% | 36.61% | 35.70% | 33.23% | 38.67% | Upgrade
|
| Operating Margin | 9.81% | 7.54% | -5.15% | -5.20% | -8.57% | 4.11% | Upgrade
|
| Profit Margin | 6.09% | 2.99% | -20.28% | -9.80% | -27.90% | 2.32% | Upgrade
|
| Free Cash Flow Margin | 21.41% | 17.64% | 5.26% | 5.62% | -2.19% | 12.59% | Upgrade
|
| EBITDA | 75.59 | 67.55 | 4.96 | 1.93 | -21.65 | 73.54 | Upgrade
|
| EBITDA Margin | 16.22% | 13.89% | 0.85% | 0.30% | -3.05% | 9.20% | Upgrade
|
| D&A For EBITDA | 29.88 | 30.88 | 34.87 | 35.43 | 39.26 | 40.65 | Upgrade
|
| EBIT | 45.71 | 36.67 | -29.91 | -33.5 | -60.91 | 32.89 | Upgrade
|
| EBIT Margin | 9.81% | 7.54% | -5.15% | -5.20% | -8.57% | 4.11% | Upgrade
|
| Effective Tax Rate | 28.04% | 33.03% | - | - | - | 17.08% | Upgrade
|
| Revenue as Reported | 486.26 | 486.26 | 581.33 | 644.62 | 710.77 | 799.83 | Upgrade
|
| Advertising Expenses | - | 4.85 | 17.77 | 24.75 | 25.27 | 30.74 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.